320 related articles for article (PubMed ID: 12432436)
1. Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome.
Tain YL; Liu CA; Yang KD
Pediatr Nephrol; 2002 Nov; 17(11):926-32. PubMed ID: 12432436
[TBL] [Abstract][Full Text] [Related]
2. [Interleukin-18 expression in peripheral blood mononuclear cells in children with steroid-resistant nephrotic syndrome].
Jiang HK; Luo G; Jiang H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):337-40. PubMed ID: 19470251
[TBL] [Abstract][Full Text] [Related]
3. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
4. Atopy in childhood idiopathic nephrotic syndrome.
Salsano ME; Graziano L; Luongo I; Pilla P; Giordano M; Lama G
Acta Paediatr; 2007 Apr; 96(4):561-6. PubMed ID: 17326761
[TBL] [Abstract][Full Text] [Related]
5. MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children.
Jafar T; Prasad N; Agarwal V; Mahdi A; Gupta A; Sharma RK; Negi MP; Agrawal S
Nephrol Dial Transplant; 2011 Dec; 26(12):3968-74. PubMed ID: 21460357
[TBL] [Abstract][Full Text] [Related]
6. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism in childhood nephrotic syndrome.
Attila G; Noyan A; Karabay Bayazit A; Acartürk E; Anarat A
Pediatr Nephrol; 2002 May; 17(5):359-62. PubMed ID: 12042894
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary analysis of urinary proteomics in children with steroid-resistant and steroid-sensitive nephrotic syndrome].
Huang AW; He QN; Zhou P; Ding JJ; Yi ZW
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):341-5. PubMed ID: 19470252
[TBL] [Abstract][Full Text] [Related]
11. [Intracellular synthesis of cytokines as the index of function of peripheral blood lymphocytes and monocytes in children with first relapse of nephrotic syndrome].
Zachwieja J; Bobkowski W; Zaniew M; Runowski D; Lewandowska-Stachowiak M; Maciejewski J
Pol Merkur Lekarski; 2003 Apr; 14(82):289-94. PubMed ID: 12868186
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome.
Aviles DH; Matti Vehaskari V; Manning J; Ochoa AC; Zea AH
Kidney Int; 2004 Jul; 66(1):60-7. PubMed ID: 15200413
[TBL] [Abstract][Full Text] [Related]
13. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
[TBL] [Abstract][Full Text] [Related]
15. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
16. [Study on the differentially expressed genes of steroid-resistant and steroid-sensitive nephrotic syndrome].
Chen RY; Yu L; Hao ZH; Wang LN; Wen YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):446-51. PubMed ID: 20017314
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
18. ACE gene polymorphism in Turkish children with nephrotic syndrome.
Celik US; Noyan A; Bayazit AK; Büyükçelik M; Dursun H; Anarat A; Attila G; Matyar S
Ren Fail; 2006; 28(5):401-3. PubMed ID: 16825089
[TBL] [Abstract][Full Text] [Related]
19. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
Fakhouri F; Bocquet N; Taupin P; Presne C; Gagnadoux MF; Landais P; Lesavre P; Chauveau D; Knebelmann B; Broyer M; Grünfeld JP; Niaudet P
Am J Kidney Dis; 2003 Mar; 41(3):550-7. PubMed ID: 12612977
[TBL] [Abstract][Full Text] [Related]
20. Implications of serum TNF-beta and IL-13 in the treatment response of childhood nephrotic syndrome.
Tain YL; Chen TY; Yang KD
Cytokine; 2003 Feb; 21(3):155-9. PubMed ID: 12697154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
